BROCKMAN MINING (00159.HK): Polaris Abandons Joint Venture Interest in Ophthalmia Project, Project Fully Held by Brockman East
NewTimeSpace News: On 19 August 2026, Brockman Mining Limited (stock code: 00159) announced that Polaris Metals Pty Limited (Polaris) abandoned its joint venture interest in the Ophthalmia project with effect from 1 July 2026. The relevant joint venture agreement was originally entered into on 22 April 2021; from 1 July 2026, the Ophthalmia project interest is wholly held by the group's wholly-owned subsidiary, Brockman East Pty Limited. The Ophthalmia project had a book value of approximately AUD 1,128,000 (approximately HKD 6,101,000) as of 30 June 2026. The group will continue to advance the Marillana project. As the announcement PDF contained font-encoding garbled characters during extraction, certain transaction terms are subject to verification against the original announcement.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HUAJIN INTL (02738.HK): Controlling Shareholder Haiyi Places 174 Million Shares Off-Market, Stake Falls from 65.25% to 36.25%
- JINTAI ENERGY H (02728.HK): Bai Jie Appointed Chairman of the Board and Nomination Committee; Han Jinfeng Steps Down as Chairman, Remains Executive Director
- HUAJIN INTL (02738.HK): Notes Unusual Price Movement of Its Shares, Board Unaware of Any Cause and Operations Remain Normal
- HUAJIN INTL(02738.HK)2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 109.11 million, loss narrowed by 79.14% YoY
- CHENGDU EXPWAY (01785.HK): Non-executive director Wu Haiyan retires; board gender diversity temporarily falls short of Listing Rules